Comparison of Treatment Outcomes among Tuberculosis Patients with HIV and Without HIV Infection in a Metropolitan City

Authors

  • Madhavi Kamble (NPCDCS) DHS, Goa
  • Yasmeen K Kazi T. N. Medical College, Mumbai

Keywords:

Tuberculosis, DOTS therapy, HIV infection, treatment outcome

Abstract

Background: Tuberculosis (TB) is a major public health problem. Along with HIV infection, it forms a deadly combination and those with these diseases are seen to have unfavourable outcomes.

Objectives: 1)To study the clinical profile of TB patients with HIV and without HIV co- infection. 2) To find the treatment outcome among the groups. 3)  To compare treatment outcomes of patients between the groups. 4) To assess associated factors influencing treatment outcome in both groups.

Methodology: The study group included sero positive Tuberculosis patients, while the control group included sero negative Tuberculosis patients. They were enquired about their demographic profile, socio-economic status, past and present TB history including their treatment details and treatment outcome. Additional information regarding the basic CD4 count diagnosis and Anti-Retroviral Therapy (ART) was collected from the study group.

Important Findings: Tuberculosis was more commonly seen in lower socioeconomic group, less educated and economically most productive group. Common symptom seen was fever, cough and weight loss. More prominent signs and symptoms were seen in seropositive patients. Weight gain was more significant in the control group. Treatment outcome was favourable among sero negative patients. 

Conclusion: Treatment outcome of tuberculosis patients on DOTS regimen depends on the HIV status of the patient.

References

World Health Organization. Global TB report 2013,. WHO Library Cataloguingin-Publication Data:14-19.

Tb India 2014 Revised National Tb Control Programme, Annual Status Report. Central TB DivisionDirectorate General of Health Services. p:29,30, 42 http://www. tbcindia.nic.in

National Framework for Joint HIV/TB Collaborative Activities. Government of India, Ministry of Health and Family Welfare, Department of AIDS Control, November 2013: 6

Shastri S., Balaji Naik, Anita Shet, Bharat Rewari, Ayesha De Costa. TB treatment outcomes among TB-HIV co-infections in Karnataka, India: how do these compare with non-HIV tuberculosis outcomes in the province? BMC Public Health 2013,13: 838. Accessed at http://www. biomedcentral.com/1471-2458/13/838 on 25/10/2014

Tripathy S., A. Anand, V. Inamdar, M.M. Manoj, K.M. Khillare, A.S. Datye, R. Iyer et al. Clinical response of newly diagnosed HIV seropositive and seronegative pulmonary tuberculosis patients with RNTCP Short Course regimen in Pune, India. Indian J Med Res, May 2011; 133(5): 521–528.

Patil V. , Vaibhav Agrawal, Sandhya Kulkarni. Treatment outcome of newly detected pulmonary Tuberculosis in HIV‑ seropositive and HIV‑seronegative patients. CHRISMED J of Health and Research. Jul-Sep 2014; 1(3): 154-163

Kamath R. , Vikram Sharma, Sanjay Pattanshetty, Mohandas B. Hegde, Varalakshmi Chandrasekaran.HIV–TB coinfection: Clinicoepidemiological determinants at an antiretroviral therapy centre in Southern India. Lung India. Oct-Dec 2013; 30(4): 302-306.

Kumar P., Niraj Sharma, N.C. Sharma and Sudhakar Patnaik.Clinical Profile of Tuberculosis in Patients with HIV Infection/AIDS. Indian J Chest Dis Allied Sci. 2002; 44: 159-163.

Ahmad Z, Mohd Shameem. Manifestations of Tuberculosis in HIV infected patients. J Ind Asso Clinical Med. 2005; 6(4): 302-305.

Gagiya A. , Nilesh Doctor, Shailendre Gamit, Ankur Patel, Khusbu Patel, Pratik Patel. Manifestations of tuberculosis in HIV/AIDS patients and its relationship with CD4 count. International Journal of Medical Science and Public Health, 2014; 3(2): 215-218.

Sharma S. , Manish Soneja, K.T. Prasad & Sanjay Ranjan. Clinical profile & predictors of poor outcome of adult HIV-tuberculosis patients in a tertiary care centre in north India. Indian J Med Res. January 2014; 139(1):154-160.

Chennaveerappa P.K., Jayashree Nagaral, Nareshkumarm .N., Praveen G., Halesha B.R., Vinaykumar M.V. TB - DOTS Outcome in Relation To HIV Status. Journal of Clinical and Diagnostic Research. 2014 Jan; 8(1): 74-76

Vijay S, Kumar P, Chauhan LS, Narayan Rao SV, Vaidyanathan P (2011) Treatment Outcome and Mortality at One and Half Year Follow-Up of HIV Infected TB Patients Under TB Control Programme in a District of South India. PLoS ONE 6(7): e21008. Accessed at https://doi.org/10.1371/ jour-nal.pone.0021008on 1/10/2014.

Vasantha M., P.G. Gopi and R. Subramani. Weight gain in patients with tuberculosis treated under Directly Observed Treatment Short Course (DOTS). Indian J Tubrc; 56: 5-9.

Chamie G., Edwin D. Charlebois, Padmini Srikantiah, Maria WalusimbiNanteza, Roy D. Mugerwa, Harriet Mayanja et al. M. tuberculosis microbiologic and clinical treatment outcomes in a randomized trial of immediate Vs CD4 initiated antiretroviral therapy in HIV-infected adults with high CD4 cell counts. Clin Infect Dis. 2010 August 1; 51 (3): 359-362.

Downloads

Published

2019-09-30

How to Cite

1.
Kamble M, Kazi YK. Comparison of Treatment Outcomes among Tuberculosis Patients with HIV and Without HIV Infection in a Metropolitan City. Natl J Community Med [Internet]. 2019 Sep. 30 [cited 2024 May 5];10(09):491-6. Available from: https://www.njcmindia.com/index.php/file/article/view/548

Issue

Section

Original Research Articles